Table 5.
The outcome of 296 patients with DTC and its relationship to BRAFV600 and TERT promoter mutations.
| Excellent response No. (%) |
Indeterminate response No. (%) |
Biochemically incomplete No. (%) |
Structurally incomplete No. (%) |
P value | |
|---|---|---|---|---|---|
| BRAF Wild type | 101 (57.7) | 23 (42.6) | 5 (35.7) | 30 (56.6) | 0.12 |
| BRAFV600E | 74 (42.3) | 31 (57.4) | 9 (64.3) | 23 (43.4) | |
| TERT wild type | 148 (84.6) | 46 (85.2) | 5 (35.7) | 25 (47.2) | <0.0001 |
| TERT promoter mutated | 27 (15.4) | 8 (14.8) | 9 (64.3) | 28 (52.8) | |
| Total | 175 | 54 | 14 | 53 | 296 |